• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常的和经基因校正的营养不良性大疱性表皮松解症成纤维细胞自身就能在基底膜区产生VII型胶原蛋白。

Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.

作者信息

Woodley David T, Krueger Gerald G, Jorgensen Cynthia M, Fairley Janet A, Atha Tom, Huang Yi, Chan Lawrence, Keene Douglas R, Chen Mei

机构信息

Department of Medicine, Division of Dermatology, University of Southern California, Los Angeles, California 90033, USA.

出版信息

J Invest Dermatol. 2003 Nov;121(5):1021-8. doi: 10.1046/j.1523-1747.2003.12571.x.

DOI:10.1046/j.1523-1747.2003.12571.x
PMID:14708601
Abstract

Type VII collagen is synthesized and secreted by both human keratinocytes and fibroblasts. Although both cell types can secrete type VII collagen, it is thought that keratinocytes account for type VII collagen at the dermal-epidermal junction (DEJ). In this study, we examined if type VII collagen secreted solely by dermal fibroblasts could be transported to the DEJ. We established organotypic, skin-equivalent cultures composed of keratinocytes from patients with recessive dystrophic epidermolysis bullosa (RDEB) and normal dermal fibroblasts. Immuno-labeling of skin equivalent sections with the anti-type VII collagen antibody revealed tight linear staining at the DEJ. RDEB fibroblasts, were gene-corrected to make type VII collagen and used to regenerate human skin on immune-deficient mice. The human skin generated by gene-corrected RDEB fibroblasts or normal human fibroblasts combined with RDEB keratinocytes restored type VII collagen expression at the DEJ in vivo. Further, intradermal injection of normal human or gene-corrected RDEB fibroblasts into mouse skin resulted in the stable expression of human type VII collagen at the mouse DEJ. These data demonstrate that human dermal fibroblasts alone are capable of producing type VII collagen at the DEJ, and it is possible to restore type VII collagen gene expression in RDEB skin in vivo by direct intradermal injection of fibroblasts.

摘要

VII型胶原蛋白由人类角质形成细胞和成纤维细胞合成并分泌。虽然这两种细胞类型都能分泌VII型胶原蛋白,但一般认为在真皮-表皮交界处(DEJ)的VII型胶原蛋白主要由角质形成细胞产生。在本研究中,我们检测了仅由真皮成纤维细胞分泌的VII型胶原蛋白是否能够转运至DEJ。我们建立了由隐性营养不良性大疱性表皮松解症(RDEB)患者的角质形成细胞和正常真皮成纤维细胞组成的器官型皮肤等效物培养体系。用抗VII型胶原蛋白抗体对皮肤等效物切片进行免疫标记,结果显示在DEJ处有紧密的线性染色。将RDEB成纤维细胞进行基因校正以使其能够产生VII型胶原蛋白,并用于在免疫缺陷小鼠身上再生人类皮肤。由基因校正的RDEB成纤维细胞或正常人类成纤维细胞与RDEB角质形成细胞联合产生的人类皮肤在体内恢复了DEJ处VII型胶原蛋白的表达。此外,将正常人类或基因校正的RDEB成纤维细胞皮内注射到小鼠皮肤中,可使人类VII型胶原蛋白在小鼠DEJ处稳定表达。这些数据表明,仅人类真皮成纤维细胞就能够在DEJ处产生VII型胶原蛋白,并且通过直接皮内注射成纤维细胞有可能在体内恢复RDEB皮肤中VII型胶原蛋白基因的表达。

相似文献

1
Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.正常的和经基因校正的营养不良性大疱性表皮松解症成纤维细胞自身就能在基底膜区产生VII型胶原蛋白。
J Invest Dermatol. 2003 Nov;121(5):1021-8. doi: 10.1046/j.1523-1747.2003.12571.x.
2
Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.恢复营养不良性大疱性表皮松解症中VII型胶原蛋白的表达及功能。
Nat Genet. 2002 Dec;32(4):670-5. doi: 10.1038/ng1041. Epub 2002 Nov 11.
3
Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.成纤维细胞疗法治疗隐性营养不良性大疱性表皮松解症的潜力。
J Invest Dermatol. 2008 Sep;128(9):2179-89. doi: 10.1038/jid.2008.78. Epub 2008 Apr 3.
4
Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector.使用自失活COL7A1逆转录病毒载体的基因校正成纤维细胞疗法治疗隐性营养不良性大疱性表皮松解症
J Invest Dermatol. 2016 Jul;136(7):1346-1354. doi: 10.1016/j.jid.2016.02.811. Epub 2016 Mar 16.
5
Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.用于隐性营养不良性大疱性表皮松解症基因治疗的皮肤替代物构建
Hum Gene Ther. 2004 Oct;15(10):921-33. doi: 10.1089/hum.2004.15.921.
6
Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa.基因矫正 iPS 细胞作为隐性营养不良型大疱性表皮松解症的细胞治疗方法。
Sci Transl Med. 2014 Nov 26;6(264):264ra165. doi: 10.1126/scitranslmed.3010083.
7
Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo.皮内注射慢病毒载体可在体内纠正再生的人营养不良性大疱性表皮松解症皮肤组织。
Mol Ther. 2004 Aug;10(2):318-26. doi: 10.1016/j.ymthe.2004.05.016.
8
Collagen VII Expression Is Required in Both Keratinocytes and Fibroblasts for Anchoring Fibril Formation in Bilayer Engineered Skin Substitutes.VII 型胶原蛋白在双层工程化皮肤替代物中锚定纤维形成既需要角质形成细胞表达,也需要成纤维细胞表达。
Cell Transplant. 2019 Sep-Oct;28(9-10):1242-1256. doi: 10.1177/0963689719857657. Epub 2019 Jul 4.
9
Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients.庆大霉素可诱导隐性营养不良型大疱性表皮松解症患者产生功能性VII型胶原蛋白。
J Clin Invest. 2017 Aug 1;127(8):3028-3038. doi: 10.1172/JCI92707. Epub 2017 Jul 10.
10
Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa.基于核糖核蛋白的 CRISPR/Cas9 和同源定向修复高效纠正 COL7A1 以治疗隐性营养不良性大疱性表皮松解症。
J Invest Dermatol. 2024 Jun;144(6):1322-1333.e13. doi: 10.1016/j.jid.2023.10.035. Epub 2023 Dec 1.

引用本文的文献

1
Progress in skin gene therapy: From the inside and out.皮肤基因治疗的进展:由内而外
Mol Ther. 2025 May 7;33(5):2065-2081. doi: 10.1016/j.ymthe.2025.03.017. Epub 2025 Mar 12.
2
Novel readthrough agent suppresses nonsense mutations and restores functional type VII collagen and laminin 332 in epidermolysis bullosa.新型通读剂可抑制大疱性表皮松解症中的无义突变,并恢复功能性VII型胶原蛋白和层粘连蛋白332。
Mol Ther Nucleic Acids. 2024 Sep 10;35(4):102334. doi: 10.1016/j.omtn.2024.102334. eCollection 2024 Dec 10.
3
Management of Skin Lesions in Patients with Epidermolysis Bullosa by Topical Treatment: Systematic Review and Meta-Analysis.
大疱性表皮松解症患者皮肤病变的局部治疗管理:系统评价与荟萃分析
Healthcare (Basel). 2024 Jan 19;12(2):261. doi: 10.3390/healthcare12020261.
4
Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects.营养不良性大疱性表皮松解症(DEB)治疗的创新:现状与前景
Ther Clin Risk Manag. 2023 Jun 14;19:455-473. doi: 10.2147/TCRM.S386923. eCollection 2023.
5
Development of Minicircle Vectors Encoding COL7A1 Gene with Human Promoters for Non-Viral Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa.开发含有 COL7A1 基因的迷你环载体,带有人类启动子,用于隐性营养不良性大疱性表皮松解症的非病毒基因治疗。
Int J Mol Sci. 2021 Nov 26;22(23):12774. doi: 10.3390/ijms222312774.
6
Clinical Perspectives of Gene-Targeted Therapies for Epidermolysis Bullosa.大疱性表皮松解症基因靶向治疗的临床前景
Dermatol Ther (Heidelb). 2021 Aug;11(4):1175-1197. doi: 10.1007/s13555-021-00561-5. Epub 2021 Jun 10.
7
Molecular mechanism of extracellular matrix disorder in pelvic organ prolapses.盆腔器官脱垂中外源性细胞基质紊乱的分子机制。
Mol Med Rep. 2020 Dec;22(6):4611-4618. doi: 10.3892/mmr.2020.11564. Epub 2020 Oct 6.
8
Gene Therapy and its Application in Dermatology.基因治疗及其在皮肤病学中的应用。
Indian J Dermatol. 2020 Sep-Oct;65(5):341-350. doi: 10.4103/ijd.IJD_323_20.
9
Toward Combined Cell and Gene Therapy for Genodermatoses.朝向基因皮肤病的联合细胞和基因治疗。
Cold Spring Harb Perspect Biol. 2020 May 1;12(5):a035667. doi: 10.1101/cshperspect.a035667.
10
Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.慢病毒成纤维细胞基因治疗隐性营养不良型大疱性表皮松解症的安全性和早期疗效结果。
JCI Insight. 2019 Jun 6;4(11). doi: 10.1172/jci.insight.126243.